WVE-006, aimed at treating alpha-1 antitrypsin deficiency (AATD), is also advancing, with regulatory engagement for potential accelerated approval expected by mid-2026
The drugs help with diabetes and weight loss, but they may also treat other conditions
No weight-loss plateau at 52 weeks
Summary Keywords IGF-1, osteogenesis, skeletal unloading, mechanotransduction, PTH, integrins, muscle-bone interactions Citation Tahimic CGT, Wang Y and Bikle DD (2013) Anabolic effects of IGF-1 signaling on the skeleton
In previous studies that compared the differentiation capacity of chondrocytes from different passages, the results indicated that cells at early passages usually generated more cartilage matrix than those at late passages upon chondroinduction ( There are several limitations in the current study